During the past decade, Centre Hospitalier Intercommunal Toulon La Seyne sur Mer conducted 48 clinical trials. In the 10-year time frame, 48 clinical trials started and 5 clinical trials were completed, i.e. on average, 10.4% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 3 clinical trials were completed. i.e. 11.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Intercommunal Toulon La Seyne sur Mer" #1 sponsor was "Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer" with 22 trials, followed by "Intergroupe Francophone de Cancerologie Thoracique" with 17 trials sponsored, "The Lymphoma Academic Research Organisation" with 4 trials sponsored, "Centre Hospitalier Universitaire de Saint Etienne" with 3 trials sponsored and "GERCOR - Multidisciplinary Oncology Cooperative Group" with 3 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Intercommunal Toulon La Seyne sur Mer" #1 collaborator was "Centre Hospitalier Universitaire de Nice" with 2 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator, "Ministry of Health, France" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "Bicetre Hospital" with 1 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 72 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Intercommunal Toulon La Seyne sur Mer" are "Carcinoma, Non-Small-Cell Lung" (4 trials), "HIV Infections" (4 trials), "Non-small Cell Lung Cancer" (3 trials), "Pulmonary Embolism" (3 trials) and "Advanced Non Small Cell Lung Cancer" (2 trials). Many other conditions were trialed in "Centre Hospitalier Intercommunal Toulon La Seyne sur Mer" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Intercommunal Toulon La Seyne sur Mer" are "Drug" (38 trials), "Other" (21 trials), "Device" (10 trials), "Procedure" (6 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Pemetrexed" (4 trials), "Chemotherapy" (3 trials), "Docetaxel" (3 trials), "Gemcitabine" (3 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Intercommunal Toulon La Seyne sur Mer" are 78 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Centre Hospitalier Intercommunal Toulon La Seyne sur Mer". undefined are not yet recruiting, 16 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 53 completed trials in Centre Hospitalier Intercommunal Toulon La Seyne sur Mer, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Intercommunal Toulon La Seyne sur Mer, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 12 trials that are defined as “Not Applicable".

Centre Hospitalier Intercommunal Toulon La Seyne sur Mer has several departments that took part in Clinical trials: "Hopital Sainte Musse; Pneumologie" - 4 trials, "Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer, Service d'infectiologie" - 2 trials